RxDoctor Payments Data

Barry Davis, DO

Family Medicine · Clackamas, ORNPI 1356324842

Payments from drug & device makers

$1,160in general payments, 2019–2025

Across 15 payments — averaging $77.35 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Vertex$904
  • Medtronic$127
  • Exact Sciences$34
  • Otsuka America Pharmaceutical, Inc.$27
  • Bayer$16
  • Sumitomo Pharma America, Inc.$15
  • plus $37 from 3 others

What the payments were for

  • Travel & lodging$76866%
  • Food & beverage$38033%
  • Education$121%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$1,160 in reported general payments places this provider in the 85th percentile of 1,221 family medicine providers in Oregon.

See all family medicine providers in Oregon

Medicare billing

Part B allowed, 2024
$61,578
Medicare patients
140
Services billed
4,003

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban77$64,536
OzempicSemaglutide49$55,243
Anoro ElliptaUmeclidinium Brm/Vilanterol Tr47$23,017
JanuviaSitagliptin Phosphate13$22,354
Trelegy ElliptaFluticasone/Umeclidin/Vilanter21$21,742
JardianceEmpagliflozin16$20,394
FarxigaDapagliflozin Propanediol18$19,741
XareltoRivaroxaban19$19,439
Spiriva HandihalerTiotropium Bromide12$16,289
Breztri AerosphereBudesonide/Glycopyr/Formoterol15$14,886
Spiriva RespimatTiotropium Bromide14$7,270
Atorvastatin Calcium550$6,967
MyrbetriqMirabegron19$6,172
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen162$4,177
Budesonide-Formoterol FumarateBudesonide/Formoterol Fumarate16$3,809

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Lilly USA, LLCHumulin N$12$3,08517 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 1,221 family medicine providers in Oregon.

Other family medicine in Clackamas

See the full list for Oregon

Where these figures come from

Is this you, or does something look wrong? →